Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last €1.52 EUR
Change Today +0.012 / 0.80%
Volume 0.0
AQL On Other Exchanges
Symbol
Exchange
NASDAQ GM
Frankfurt
As of 3:54 PM 07/31/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Brian Schwartz M.D.

Chief Medical Officer and Senior Vice President of Clinical & Regulatory Affairs, ArQule Inc.
AgeTotal Calculated CompensationThis person is connected to 0 board members in 0 different organizations across 2 different industries.

53$723,569
As of Fiscal Year 2014

Background*

Dr. Brian Schwartz, MD has been the Chief Medical Officer and Senior Vice President of Clinical and Regulatory Affairs at ArQule Inc. since July 14, 2008. Dr. Schwartz served as Senior Vice President of Medical & Regulatory Affairs and Chief Medical Officer of Ziopharm Oncology, Inc. from June 1, 2006 to July 11, 2008. He has extensive regulatory experience in working with the U.S. Food and Drug Administration Oncology Division, the European Medicines Evaluation Agency, ...

Read Full Background

Corporate Headquarters*

One Wall Street
Burlington, Massachusetts 01803

United States

Phone: 781-994-0300
Fax: 781-376-6019

Board Members Memberships*

There is no Board Members Memberships data available.

Education*

MD
University of Pretoria

Other Affiliations*

Annual Compensation*

Salary$394,597
Total Annual Compensation$394,597

Stock Options*

All Other Compensation$8,400
Exercisable Options471,125
Unexercisable Options260,375
Total Number of Options731,500

Total Compensation*

Total Annual Cash Compensation$537,758
Total Short Term Compensation$394,597
Other Long Term Compensation$8,400
Total Calculated Compensation$723,569
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
AQL:GR €1.52 EUR +0.012

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Ali Fattaey Ph.D.Chief Executive Officer, President and Director
Curis, Inc.
$464.2K
Robert I. Blum Chief Executive Officer, President, Director and Chief Executive of the Biopharmaceutical Concern
Cytokinetics, Incorporated
$555.0K
Raul R. Rodriguez Chief Executive Officer, President, Director and Member of Finance Committee
Rigel Pharmaceuticals, Inc.
$551.7K
Michael P. Bailey Chief Executive Officer, President, Secretary and Director
AVEO Pharmaceuticals, Inc.
$504.1K
Myung-Joong Cho Ph.D.Founder, Chief Executive Officer and President
CrystalGenomics, Inc.
--
Compensation as of Fiscal Year 2014.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ARQULE INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.